Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 235,133 | 175,513 | 134,030 | 45,605 | 50,118 |
| Cost of Goods | 28,248 | 14,148 | 5,664 | 1,091 | N/A |
| Gross Profit | 206,885 | 161,365 | 128,366 | 44,514 | N/A |
| Operating Expenses | 188,466 | 253,056 | 239,836 | 225,249 | 147,599 |
| Operating Income | 18,419 | -91,691 | -111,470 | -180,735 | -97,481 |
| Interest Expense | 4,835 | 2,775 | N/A | N/A | N/A |
| Other Income | -6,136 | 16,997 | 5,118 | 529 | -5,293 |
| Pre-tax Income | 7,448 | -77,469 | -106,352 | -180,206 | -102,774 |
| Income Tax | 1,696 | 551 | 1,828 | 760 | -94 |
| Net Income Continuous | 5,752 | -78,020 | -108,180 | -180,966 | -102,680 |
| Net Income | $5,752 | $-78,020 | $-108,180 | $-180,966 | $-102,680 |
| EPS Basic Total Ops | N/A | N/A | N/A | N/A | -0.87 |
| EPS Basic Continuous Ops | N/A | N/A | N/A | N/A | -0.87 |
| EPS Diluted Total Ops | N/A | N/A | N/A | N/A | -0.87 |
| EPS Diluted Continuous Ops | N/A | N/A | N/A | N/A | -0.87 |
| EBITDA(a) | $31,728 | $-63,047 | $-108,764 | $-177,974 | $-96,110 |